Literature DB >> 8036021

Clonal evolution of malignant and non-malignant T cells carrying t(14;14) and t(X;14) in patients with ataxia telangiectasia.

P D Sherrington1, P Fisch, A M Taylor, T H Rabbitts.   

Abstract

People with ataxia telangiectasia (AT) are at a higher than normal risk of T cell leukaemia and often have either non-malignant or malignant T cells with chromosomal abnormalities, typically t(14;14), inversion 14 or more rarely t(X;14). This provides a chance to study the pre-leukaemic phase of the disease. T cells have been studied with either t(14;14)(q11;q32.1) or t(X;14)(q28;q11) from two AT sisters of which the latter developed T cell leukaemia. The telomeric breakpoint of the t(14;14) was cloned and found to occur at 14q32.1 where known tumour-associated breakpoints are located, but the patient remains asymptomatic for leukaemia. Analysis of T cell populations in both patients showed that the cells containing the translocation became oligoclonal with respect to T cell receptor beta rearrangement and complete T cell receptor beta clonality was only established in the patient with t(X;14) by onset of overt disease. Therefore in these chronic diseases, chromosomal translocations can precede T cell receptor rearrangement suggesting a role for these abnormalities as early events of malignant outgrowth.

Entities:  

Mesh:

Year:  1994        PMID: 8036021

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

Review 1.  Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints.

Authors:  Y Shiloh; G Rotman
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

2.  Deregulated expression of TCL1 causes T cell leukemia in mice.

Authors:  L Virgilio; C Lazzeri; R Bichi; K Nibu; M G Narducci; G Russo; J L Rothstein; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Solution structure of the recombinant human oncoprotein p13MTCP1.

Authors:  Y S Yang; L Guignard; A Padilla; F Hoh; M P Strub; M H Stern; J M Lhoste; C Roumestand
Journal:  J Biomol NMR       Date:  1998-04       Impact factor: 2.835

4.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.